{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:00:15Z","timestamp":1781067615234,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020555","name":"Ospedale Pediatrico Bambino Ges\u00f9","doi-asserted-by":"publisher","award":["Ricerca Corrente 5 \u00d7 1000 from Bambino Ges\u00f9 Children' s Hospital (202205_INFETT_CIFALDI)"],"award-info":[{"award-number":["Ricerca Corrente 5 \u00d7 1000 from Bambino Ges\u00f9 Children' s Hospital (202205_INFETT_CIFALDI)"]}],"id":[{"id":"10.13039\/100020555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12369979"],"award-info":[{"award-number":["GR-2019-12369979"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["EPPERMED2024-308"],"award-info":[{"award-number":["EPPERMED2024-308"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Biallelic loss-of-function mutations in the GTPase of immunity-associated protein 5 (\n                      <jats:italic>GIMAP5<\/jats:italic>\n                      ) cause a severe syndrome characterized by altered immunity, lymphoproliferation, and progressive hepatopathy. This study aims to delineate the immunophenotypic signatures and clinical management of this deficiency by reporting the first Italian pediatric case alongside his mono-allelic carrier twin, integrated with a review of twenty previously published patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized trio-based clinical exome sequencing, flow cytometric immunophenotyping, protein expression profiling, and curated database analysis to evaluate the clinical trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 11-year-old proband presented with autoimmune cytopenias, severe viral infections, and early biochemical liver anomalies. Genetic analysis identified compound heterozygous variants (p.Leu204Pro and p.Arg214Ter) in\n                      <jats:italic>GIMAP5<\/jats:italic>\n                      gene resulting in absent protein expression, alongside an expanded atypical memory B-cell population and T-cell exhaustion. Notably, his dizygotic twin harbored the heterozygous p.Leu204Pro variant and exhibited decreased protein expression coupled with a localized fibro-adipose vascular anomaly, but lacked immune defects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This observation suggests complex genotype-phenotype interactions, raising the question of whether partial GIMAP5 deficiency might subtly predispose to localized vascular anomalies under specific environmental or epigenetic conditions, likely requiring multi-hit mechanisms. Therapeutically, the proband achieved sustained clinical remission of cytopenias through immunomodulation with the mTOR inhibitor sirolimus. These findings expand the phenotypic spectrum of this disorder, underscoring a dual role in immune and endothelial homeostasis. Furthermore, the successful application of sirolimus highlights the efficacy of precision medical management as a viable strategy to stabilize patients, allowing time to carefully weigh the risks and benefits of definitive interventions, such as hematopoietic stem cell transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1820281","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:29:00Z","timestamp":1781065740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT"],"prefix":"10.3389","volume":"17","author":[{"given":"Mattia","family":"Moratti","sequence":"first","affiliation":[{"name":"Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna","place":["Bologna, Italy"]},{"name":"PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata","place":["Rome, Italy"]},{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"La Manna","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Cell and Gene Therapy, Bambino Ges\u00f9 Children\u2019s Hospital, Scientific Institute for Research and Healthcare (IRCCS)","place":["Rome, Italy"]},{"name":"Residency School of Pediatrics , University of Rome \u201cTor Vergata\u201d","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Colucci","sequence":"additional","affiliation":[{"name":"PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata","place":["Rome, Italy"]},{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cifaldi","sequence":"additional","affiliation":[{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]},{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Di Cesare","sequence":"additional","affiliation":[{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]},{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino Andrea","family":"Rotulo","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Vaccinology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rivalta","sequence":"additional","affiliation":[{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]},{"name":"Clinical Immunology and Vaccinology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Amodio","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]},{"name":"Clinical Immunology and Vaccinology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pietrobattista","sequence":"additional","affiliation":[{"name":"Metabolic Diseases and Hepatology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Caballero-Oteyza","sequence":"additional","affiliation":[{"name":"Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Hospital Freiburg","place":["Freiburg, Germany"]},{"name":"RESiST-Cluster of Excellence 2155, Hanover Medical School","place":["Hanover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Lembo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Cell and Gene Therapy, Bambino Ges\u00f9 Children\u2019s Hospital, Scientific Institute for Research and Healthcare (IRCCS)","place":["Rome, Italy"]},{"name":"Residency School of Pediatrics , University of Rome \u201cTor Vergata\u201d","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Passarelli","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Concetta","family":"Manno","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Vaccinology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Proietti","sequence":"additional","affiliation":[{"name":"Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Hospital Freiburg","place":["Freiburg, Germany"]},{"name":"RESiST-Cluster of Excellence 2155, Hanover Medical School","place":["Hanover, Germany"]},{"name":"Clinic for Immunology and Rheumatology, Hanover Medical School","place":["Hanover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigliola","family":"Di Matteo","sequence":"additional","affiliation":[{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]},{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology and Cell and Gene Therapy, Bambino Ges\u00f9 Children\u2019s Hospital, Scientific Institute for Research and Healthcare (IRCCS)","place":["Rome, Italy"]},{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[{"name":"Research Unit of Primary Immunodeficiencies, Bambino Gesu\u2019 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]},{"name":"Department of Systems Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]},{"name":"Clinical Immunology and Vaccinology Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41467-018-02897-7","article-title":"Gimap5-dependent inactivation of GSK3\u03b2 is required for CD4+ T cell homeostasis and prevention of immune pathology","volume":"9","author":"Patterson","year":"2018","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201745","article-title":"GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension","volume":"218","author":"Drzewiecki","year":"2021","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaci.2018.10.018","article-title":"Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4+ T-cell development and allergic airway disease","volume":"143","author":"Patterson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01691-y","article-title":"GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway","volume":"25","author":"Park","year":"2024","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01736-2","article-title":"When ceramides meet immune senescence, a GIMAP5 connection","volume":"25","author":"Gope","year":"2024","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.22.432146","article-title":"Human immunodeficiency reveals GIMAP5 as lymphocyte-specific regulator of senescence","author":"Park","year":"2021"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.01.038","article-title":"Clinicopathological features of porto-sinusoidal vascular disorder with a novel GIMAP5 mutation in a pair of twin siblings","volume":"57","author":"Hu","year":"2025","journal-title":"Digestive Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000973","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder","volume":"83","author":"Ciriaci","year":"2024","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139019","article-title":"GIMAP5 deficiency is associated with increased AKT activity in T lymphocytes","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.679739","article-title":"The GIMAP family proteins: an incomplete puzzle","volume":"12","author":"Limoges","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.152877","article-title":"Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention","volume":"230","author":"Fan","year":"2025","journal-title":"Immunobiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101206","article-title":"Loss of immunological tolerance in gimap5-deficient mice is associated with loss of foxo in CD4+ T cells","volume":"188","author":"Aksoylar","year":"2012","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2016.09.010","article-title":"Incidence and prevention of herpes zoster reactivation in patients with autoimmune diseases","volume":"43","author":"Chakravarty","year":"2017","journal-title":"Rheumatic Dis Clinics North America"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10875-024-01854-y","article-title":"Pre-transplant immune dysregulation predicts for poor outcome following allogeneic haematopoietic stem cell transplantation in adolescents and adults with inborn errors of immunity (IEI)","volume":"45","author":"Fox","year":"2025","journal-title":"J ClinImmunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015506","article-title":"Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study","volume":"140","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10875-024-01835-1","article-title":"Report of the italian cohort with activated phosphoinositide 3-kinase \u03b4 Syndrome in the target therapy era","volume":"45","author":"Barzaghi","year":"2024","journal-title":"J ClinImmunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250125","article-title":"Leniolisib reduced lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome","volume":"2","author":"Hassan","year":"2026","journal-title":"J Hum Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.11.022","article-title":"GenIA, the Genetic Immunology Advisor database for inborn errors of immunity","volume":"153","author":"Caballero-Oteyza","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:29:02Z","timestamp":1781065742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2026.1820281"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1820281","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1820281"}}